A61L2300/60

Powder for achieving hemostasis

In various aspects, the present disclosure pertains to methods of treating or preventing bleeding at a tissue site comprising applying a chitosan powder composition to the tissue site. In various aspects, the present disclosure pertains to chitosan powder compositions for application to a tissue site, where the powder compositions comprise a chitosan salt, a crosslinked chitosan, a derivatized chitosan, or a combination thereof. In various aspects, the disclosure pertains to catheter assemblies, which are preloaded with a chitosan powder composition and which are configured to deliver the chitosan powder composition a tissue site.

Placental tissue grafts and methods of preparing and using the same
11504449 · 2022-11-22 · ·

A method for preparing placenta membrane tissue grafts for medical use, includes obtaining a placenta from a subject, cleaning the placenta, separating the chorion tissue from the amniotic membrane, mounting a selected layer of either the chorion tissue or the amniotic membrane onto a drying fixture, dehydrating the selected layer on the drying fixture, and cutting the selected layer into a plurality of tissue grafts. Preferably, the drying fixture includes grooves or raised edges that define the outer contours of each desired tissue graft, after they are cut, and further includes raised or indented logos that emboss the middle area of the tissue grafts during dehydration and that enables an end user to distinguish the top from the bottom side of the graft. The grafts are comprised of single layers of amnion or chorion, multiple layers of amnion or chorion, or multiple layers of a combination of amnion and chorion.

PLACENTAL TISSUE GRAFTS AND IMPROVED METHODS OF PREPARING AND USING THE SAME
20230201419 · 2023-06-29 · ·

A method for preparing placenta membrane tissue grafts for medical use, includes obtaining a placenta from a subject, cleaning the placenta, separating the chorion tissue from the amniotic membrane, mounting a selected layer of either the chorion tissue or the amniotic membrane onto a drying fixture, dehydrating the selected layer on the drying fixture, and cutting the selected layer into a plurality of tissue grafts. Preferably, the drying fixture includes grooves or raised edges that define the outer contours of each desired tissue graft, after they are cut, and further includes raised or indented logos that emboss the middle area of the tissue grafts during dehydration and that enables an end user to distinguish the top from the bottom side of the graft. The grafts are comprised of single layers of amnion or chorion, multiple layers of amnion or chorion, or multiple layers of a combination of amnion and chorion.

DEVICES COMPRISING HYALURONIC ACID AND SILK FIBROIN
20230201414 · 2023-06-29 ·

The present disclosure provides biocompatible and bioresorbable devices for tissue repair and regeneration and delivery of an active agent across a biological barrier comprising silk fibroin and hyaluronic acid.

Method for producing collagen-containing sheet material

A method for producing a collagen-containing sheet material, wherein a collagen-containing suspension is dried in such a manner that the collagen settles during drying and forms a transparent skin.

ANTI-MICROBIAL ARTICLES

An article. The article includes a substrate, wherein the substrate having two opposing major surfaces; and particles coated with a metal oxide on the substrate: particles coated with a metal on the substrate; wherein the coated particles are randomly distributed on or in the substrate; and wherein at least some of coated particles are discrete particles.

Bioactive Grafts and Composites
20170312386 · 2017-11-02 ·

Disclosed are various bioactive and/or biocompatible materials and methods of making the same.

Inhibiting Post-Biopsy Inflammation and Metastasis
20220039907 · 2022-02-10 ·

A method of inhibiting cancer cell metastasis in a subject by providing a biopsy marker device constructed of a polymeric material, the polymeric material containing an anti-inflammatory agent which is releasable over an extended period of time from the polymeric material after the biopsy marker device has been implanted in a tissue of the subject, and implanting the biopsy marker device into a tissue cavity of the subject, wherein the tissue cavity is caused by a biopsy performed on a tumor in the subject, and wherein release of the anti-inflammatory agent from the polymeric material does not begin for at least 18 to 24 hours after implantation and continues for at least 14 to 60 days after implantation. Metastasis of cancer cells from the tissue cavity is inhibited when the tumor is cancerous. The tissue may be, for example, breast, lung, prostate, pancreas, liver, kidney, uterus, ovary, intestine, stomach, or neck tissue.

Hydrogel system comprising spatially separated bioactive polypeptides

The present invention provides a multi-compartment hydrogel, and a sulfated polysaccharide and at least two bioactive polypeptides capable of binding said sulfated polysaccharide, for use in repair or regeneration of a damaged tissue in a mammal. Also provided is a method for constructing the multi-compartment hydrogel. The present invention also provides a method for the repair or regeneration of a damaged tissue in a mammal, and a kit for constructing a multi-compartment hydrogel.

FUNCTIONALIZING NANOFIBRES
20170252460 · 2017-09-07 ·

Methods for functionalizing the surface of nanofiber substrates, including electrospun fibres and non-woven or woven mats of fibres are described. Functionalised nanofiber substrates presenting biologically active moieties such as biotin and saccharides are described.